No sufficient, verifiable information is available in the provided prompt to identify the suppliers (manufacturers, API vendors, contract manufacturing organizations, or distributors) for the pharmaceutical drug XURIDEN.
What supplier data is required to answer
A complete supplier map typically needs at least one of the following, tied to the specific drug and strength:
Regulatory label/approval dossier (applicant/holder, manufacturer, API source, testing sites)
NDC/marketing authorization entry listing manufacturer and distributor
Package insert naming manufacturing sites and labeler
Patent prosecution documents naming suppliers or manufacturing arrangements
Public procurement and launch documents listing contract manufacturers
Key Takeaways
Supplier identification for XURIDEN cannot be produced from the information provided.
A defensible supplier answer requires drug-specific regulatory or labeling sources that are not included in the prompt.
FAQs
What counts as a “supplier” for a drug?
Labeler (marketing authorization holder), finished-dose manufacturer, API manufacturer(s), contract manufacturer(s), and sometimes distributors.
Why can’t supplier names be derived from the drug name alone?
Drug names can be reused across markets, strengths, and formulations, and “supplier” can refer to multiple parties.
Which filings most reliably list drug suppliers?
Marketing authorization applications/approvals, package inserts, and regulatory submissions that enumerate manufacturing and testing sites.
Can patents alone identify suppliers?
Sometimes, but patents rarely provide a complete, current supply chain without linked regulatory or label evidence.
What source types are typically used for an audit-grade supplier list?
Regulatory label data (e.g., package inserts, approval listings), NDC entries, and dossier-linked manufacturing statements.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
